Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.

Panchaud A, Rousson V, Vial T, Bernard N, Baud D, Amar E, De Santis M, Pistelli A, Dautriche A, Beau-Salinas F, Cassina M, Dunstan H, Passier A, Kaplan YC, Duman MK, Maňáková E, Eleftheriou G, Klinger G, Winterfeld U, Rothuizen LE, Buclin T, Csajka C, Hernandez-Diaz S.

Br J Clin Pharmacol. 2018 Mar;84(3):568-578. doi: 10.1111/bcp.13481. Epub 2018 Jan 14.

PMID:
29215149
2.

Pregnancy outcome following maternal exposure to pregabalin may call for concern.

Winterfeld U, Merlob P, Baud D, Rousson V, Panchaud A, Rothuizen LE, Bernard N, Vial T, Yates LM, Pistelli A, Ellfolk M, Eleftheriou G, de Vries LC, Jonville-Bera AP, Kadioglu M, Biollaz J, Buclin T.

Neurology. 2016 Jun 14;86(24):2251-7. doi: 10.1212/WNL.0000000000002767. Epub 2016 May 18.

PMID:
27194385
3.

[Pharmacovigilance update].

Dao K, Chtioui H, Rothuizen LE, Diezi L, Prod'hom S, Winterfeld U, Buclin T, Livio F.

Rev Med Suisse. 2016 Jan 13;12(500):75-9. French.

PMID:
26946710
4.

Spectrum of digoxin-induced ocular toxicity: a case report and literature review.

Renard D, Rubli E, Voide N, Borruat FX, Rothuizen LE.

BMC Res Notes. 2015 Aug 23;8:368. doi: 10.1186/s13104-015-1367-6. Review.

5.

Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.

Winterfeld U, Klinger G, Panchaud A, Stephens S, Arnon J, Malm H, Te Winkel B, Clementi M, Pistelli A, Maňáková E, Eleftheriou G, Merlob P, Kaplan YC, Buclin T, Rothuizen LE.

J Clin Psychopharmacol. 2015 Jun;35(3):250-9. doi: 10.1097/JCP.0000000000000309.

PMID:
25830592
6.

Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.

Weber-Schoendorfer C, Oppermann M, Wacker E, Bernard N; network of French pharmacovigilance centres, Beghin D, Cuppers-Maarschalkerweerd B, Richardson JL, Rothuizen LE, Pistelli A, Malm H, Eleftheriou G, Kennedy D, Kadioglu Duman M, Meister R, Schaefer C.

Br J Clin Pharmacol. 2015 Oct;80(4):727-39. doi: 10.1111/bcp.12642. Epub 2015 May 28.

7.

[Pharmacovigilance update].

Fogarasi Szabo N, Diezi L, Delenclos L, Renard D, Chtioui H, Rothuizen LE, Buclin T, Livio F.

Rev Med Suisse. 2015 Jan 14;11(456-457):124-8. French.

PMID:
25799668
8.

Perampanel: a significant liver enzyme inducer in some patients?

Novy J, Rothuizen LE, Buclin T, Rossetti AO.

Eur Neurol. 2014;72(3-4):213-6. doi: 10.1159/000362446. Epub 2014 Sep 13.

PMID:
25227593
9.

[Antiepileptics in women of childbearing age and during pregnancy: comparison of specialized information with the current state of knowledge in Germany and Switzerland].

Winterfeld U, Gotta V, Rothuizen LE, Panchaud A, Rossetti AO, Buclin T.

Nervenarzt. 2014 Jun;85(6):738-46. doi: 10.1007/s00115-014-4091-x. German.

PMID:
24861194
10.

[Pharmacovigilance update].

Diezi L, Renard D, Rothuizen LE, Livio F.

Rev Med Suisse. 2014 Jan 15;10(412-413):119-22. Review. French.

PMID:
24558915
11.

Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications.

Winterfeld U, Allignol A, Panchaud A, Rothuizen LE, Merlob P, Cuppers-Maarschalkerweerd B, Vial T, Stephens S, Clementi M, De Santis M, Pistelli A, Berlin M, Eleftheriou G, Maňáková E, Buclin T.

BJOG. 2013 Oct;120(11):1440. doi: 10.1111/1471-0528.12280. No abstract available.

12.

Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.

Winterfeld U, Allignol A, Panchaud A, Rothuizen LE, Merlob P, Cuppers-Maarschalkerweerd B, Vial T, Stephens S, Clementi M, De Santis M, Pistelli A, Berlin M, Eleftheriou G, Maňáková E, Buclin T.

BJOG. 2013 Mar;120(4):463-71. doi: 10.1111/1471-0528.12066. Epub 2012 Nov 30.

13.

Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study.

Panchaud A, Csajka C, Merlob P, Schaefer C, Berlin M, De Santis M, Vial T, Ieri A, Malm H, Eleftheriou G, Stahl B, Rousso P, Winterfeld U, Rothuizen LE, Buclin T.

J Clin Pharmacol. 2012 Dec;52(12):1844-51. doi: 10.1177/0091270011429566. Epub 2011 Dec 15.

PMID:
22174426
14.

Effect of dronedarone on renal function in healthy subjects.

Tschuppert Y, Buclin T, Rothuizen LE, Decosterd LA, Galleyrand J, Gaud C, Biollaz J.

Br J Clin Pharmacol. 2007 Dec;64(6):785-91. Epub 2007 Jul 27.

15.

[Effects of oral cannabis and dronabinol on driving capacity].

Giroud C, Augsburger M, Favrat B, Menetrey A, Pin MA, Rothuizen LE, Appenzeller M, Buclin T, Mathieu S, Castella V, Hazekamp A, Mangin P.

Ann Pharm Fr. 2006 May;64(3):161-72. French.

PMID:
16710114
16.

[Risk of overtreatment: not to be neglected. The example of antiepileptic drugs].

Rothuizen LE, Buclin T, Reichhart M, Biollaz J.

Rev Med Suisse. 2006 Apr 12;2(61):976-80. Review. French.

PMID:
16686330
17.
18.

Two cases of "cannabis acute psychosis" following the administration of oral cannabis.

Favrat B, Ménétrey A, Augsburger M, Rothuizen LE, Appenzeller M, Buclin T, Pin M, Mangin P, Giroud C.

BMC Psychiatry. 2005 Apr 1;5:17.

19.

Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers.

Rothuizen LE, Buclin T, Spertini F, Trinchard I, Munafo A, Buchwalder PA, Ythier A, Biollaz J.

J Neuroimmunol. 1999 Sep 1;99(1):131-41.

PMID:
10496186

Supplemental Content

Loading ...
Support Center